Cargando…

Allied Health Professional Support in Pediatric Inflammatory Bowel Disease: A Survey from the Canadian Children Inflammatory Bowel Disease Network—A Joint Partnership of CIHR and the CH.I.L.D. Foundation

OBJECTIVES: The current number of healthcare providers (HCP) caring for children with inflammatory bowel disease (IBD) across Canadian tertiary-care centres is underinvestigated. The aim of this survey was to assess the number of healthcare providers (HCP) in ambulatory pediatric IBD care across Can...

Descripción completa

Detalles Bibliográficos
Autores principales:	El-Matary, Wael, Benchimol, Eric I., Mack, David, Huynh, Hien Q., Critch, Jeff, Otley, Anthony, Deslandres, Colette, Jacobson, Kevan, deBruyn, Jennifer, Carroll, Matthew W., Wine, Eytan, Van Limbergen, Johan, Sherlock, Mary, Bax, Kevin, Lawrence, Sally, Seidman, Ernest, Issenman, Robert, Walters, Thomas D., Church, Peter, Griffiths, Anne M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5448041/ https://www.ncbi.nlm.nih.gov/pubmed/28593172 http://dx.doi.org/10.1155/2017/3676474

Ejemplares similares

Editorial: Pediatric Inflammatory Bowel Diseases: Looking to the Future
por: Wine, Eytan, et al.
Publicado: (2020)

A23 ESTIMATING INDIRECT AND OUT-OF-POCKET COSTS IN PEDIATRIC INFLAMMATORY BOWEL DISEASE: A NATION-WIDE CROSS-SECTIONAL ANALYSIS
por: El-Matary, W, et al.
Publicado: (2022)

Canadian Association of Gastroenterology Clinical Practice Guideline for the Medical Management of Pediatric Luminal Crohn’s Disease
por: Mack, David R, et al.
Publicado: (2019)

Nutritional Therapies and Their Influence on the Intestinal Microbiome in Pediatric Inflammatory Bowel Disease
por: Hart, Lara, et al.
Publicado: (2021)

The 2023 Impact of Inflammatory Bowel Disease in Canada: Special Populations—Children and Adolescents with IBD
por: El-Matary, Wael, et al.
Publicado: (2023)

A Comparison of Preference-Based, Generic and Disease-Specific Health-Related Quality of Life in Pediatric Inflammatory Bowel Disease
por: Bashir, Naazish S, et al.
Publicado: (2023)

Clinical and Laboratory Characteristics Are Associated With Biologic Therapy Use in Pediatric Inflammatory Bowel Disease: A Retrospective Cohort Study
por: Sherlock, Mary E, et al.
Publicado: (2020)

A comparison of the Child Health Utility 9D and the Health Utilities Index for estimating health utilities in pediatric inflammatory bowel disease
por: Bashir, Naazish S., et al.
Publicado: (2023)

Inflammatory Bowel Disease and the Environment: More to Come
por: El-Matary, Wael
Publicado: (2020)

Regulation of Nuclear Factor Kappa-Light-Chain-Enhancer of Activated B Cells (NF-κβ) in Inflammatory Bowel Diseases
por: Zaidi, Deenaz, et al.
Publicado: (2018)

Advances in Nutritional Management of Pediatric Inflammatory Bowel Disease
por: El-Matary, Wael
Publicado: (2021)

Rural and urban disparities in the care of Canadian patients with inflammatory bowel disease: a population-based study
por: Benchimol, Eric I, et al.
Publicado: (2018)

Therapeutic drug monitoring for biological medications in inflammatory bowel disease
por: Cogan, Rachel C., et al.
Publicado: (2022)

The Impact of Inflammatory Bowel Disease in Canada 2018: Children and Adolescents with IBD
por: Carroll, Matthew W, et al.
Publicado: (2019)

Thiopurine Methyltransferase Activity and Thiopurine Metabolites in Inflammatory Bowel Disease
por: El-Matary, Wael
Publicado: (2020)

The Frequency of Clinic Visits Was Not Associated with Medication Adherence or Outcome in Children with Inflammatory Bowel Diseases
por: Kluthe, Cheryl, et al.
Publicado: (2018)

A183 VARIATION IN HEALTH SERVICES UTILIZATION AND RISK OF SURGERY ACROSS CHILDREN WITH INFLAMMATORY BOWEL DISEASE: A MULTIPROVINCE COHORT STUDY
por: Kuenzig, E, et al.
Publicado: (2023)

Hospitalization With Clostridioides difficile in Pediatric Inflammatory Bowel Disease: a Population-Based Study
por: Kuenzig, M. Ellen, et al.
Publicado: (2022)

The Impact of Inflammatory Bowel Disease in Canada 2018: Quality of Life
por: Jones, Jennifer L, et al.
Publicado: (2019)

Cancer Risk in Pediatric-Onset Inflammatory Bowel Disease
por: El-Matary, Wael, et al.
Publicado: (2020)

Micronutrient Deficiencies and Anemia in Children with Inflammatory Bowel Disease
por: Rempel, Julie, et al.
Publicado: (2021)

Garlic (Allium sativum L.) as an Ally in the Treatment of Inflammatory Bowel Diseases
por: Zugaro, Silvana, et al.
Publicado: (2023)

Trends in Epidemiology of Pediatric Inflammatory Bowel Disease in Canada: Distributed Network Analysis of Multiple Population-Based Provincial Health Administrative Databases
por: Benchimol, Eric I, et al.
Publicado: (2017)

The Challenges of Living with Inflammatory Bowel Disease: Summary of a Summit on Patient and Healthcare Provider Perspectives
por: Bray, Judith, et al.
Publicado: (2016)

Rural and Urban Residence During Early Life is Associated with Risk of Inflammatory Bowel Disease: A Population-Based Inception and Birth Cohort Study
por: Benchimol, Eric I, et al.
Publicado: (2017)

Barriers to clinical research in children with inflammatory bowel disease: The patients' perspective
por: El-Matary, Wael, et al.
Publicado: (2018)

Therapeutic drug monitoring in inflammatory bowel disease
por: Kopylov, Uri, et al.
Publicado: (2014)

Defining Transition Success for Young Adults with Inflammatory Bowel Disease According to Patients, Parents and Health Care Providers
por: Bihari, Allison, et al.
Publicado: (2022)

A171 INTESTINAL INTERFERON-LAMBDA RECEPTOR 1 EXPRESSION AND RESPONSES ARE SIGNIFICANTLY DECREASED IN PEDIATRIC INFLAMMATORY BOWEL DISEASE PATIENTS
por: Ogungbola, O, et al.
Publicado: (2023)

Epstein–Barr virus seroprevalence and viral load at disease onset in children with inflammatory bowel disease
por: Kornitzer, Gaël, et al.
Publicado: (2022)

A189 EMERGENCY DEPARTMENT UTILIZATION AND RISK OF INTESTINAL RESECTION IS LOWER AMONG CHILDREN DIAGNOSED WITH INFLAMMATORY BOWEL DISEASE BEFORE 10 YEARS OF AGE: A MULTIPROVINCE POPULATION-BASED COHORT STUDY
por: Kuenzig, E, et al.
Publicado: (2023)

Phenotype and outcomes of very early onset and early onset inflammatory bowel diseases in a Montreal pediatric cohort
por: Chapuy, Laurence, et al.
Publicado: (2023)

A182 PREDICTING HIGH DIRECT HEALTHCARE COSTS IN PEDIATRIC PATIENTS WITH INFLAMMATORY BOWEL DISEASE IN THE FIRST YEAR FOLLOWING DIAGNOSIS
por: Kuenzig, E, et al.
Publicado: (2023)

Inflammatory Bowel Disease Increases the Risk of Venous Thromboembolism in Children: A Population-Based Matched Cohort Study
por: Kuenzig, M Ellen, et al.
Publicado: (2021)

The Impact of Inflammatory Bowel Disease in Canada 2018: Indirect Costs of IBD Care
por: Kuenzig, M Ellen, et al.
Publicado: (2019)

Corrigendum: Rural and Urban Residence During Early Life Is Associated with a Lower Risk of Inflammatory Bowel Disease: A Population-Based Inception and Birth Cohort Study
por: Benchimol, Eric I, et al.
Publicado: (2017)

Probiotics in Inflammatory Bowel Diseases and Associated Conditions
por: Mack, David R.
Publicado: (2011)

Poor Clinician Adherence to Inflammatory Bowel Disease Guidelines: How Do We Remedy the Situation?
por: Hart, Lara, et al.
Publicado: (2022)

Comparison of Fecal Calprotectin Methods for Predicting Relapse of Pediatric Inflammatory Bowel Disease
por: Kittanakom, Saranya, et al.
Publicado: (2017)

Early Serum Infliximab Levels in Pediatric Ulcerative Colitis
por: deBruyn, Jennifer C. C., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9m3rg5f6nd4e2ou26cu36uibo0